Healthcare is an intense ecosystem where each pill and treatment holds the hopes of thousands. It is sometimes just a question of strategy and passion whether a treatment reaches a patient or ends up on a shelf, either in a large hospital or a small clinic. It’s a junction where data meets empathy, market trends blend with human stories, and a leader’s vision can transform multiple healing journeys. One of the prime domains in healthcare is gynecology. The sensitive and essential aspect of this sector requires more than knowledge; it requires a desire to bridge the science and accessibility to integrate advanced therapies. Dr. Rajeev Agarwal, President, Gufic Biosciences Ltd, steps into this arena with a commanding presence! His 30 years in pharmaceutical sales and marketing paint a vivid story of impact. He specializes in gynecology and multispecialty treatments. Rather than being a strategist, he is a sculptor of markets, opening opportunities where others find impediments. He manages a dynamic workforce of 800 and has stimulated EBITDA growth by introducing groundbreaking products like Gyargin, Vehycal, Naturogest 300/Gel, and Dydrofem. His campaigns for brands such as Menagon, Decapetyl Depot, and Orofer XT have transformed therapy landscapes, establishing a balance between careful market studies and aggressive marketing moves. With training courses, client partnerships, and unstoppable innovation, Dr. Agarwal not only exceeds the targets; he is shaping a new reality in women’s healthcare. Among these interests, he is fond of singing, which he finds both therapeutic and inspiring, often recharging his energy and creativity. Redefining Fertility Care Through Science and Soul Dr. Rajeev Agarwal is a visionary leader with 29 years of experience in building and scaling pharmaceutical businesses across IVF, gynecology, and specialty care. Raised in a family that valued education and service, he pursued advanced studies culminating in a doctoral qualification, laying a strong foundation for a career at the intersection of science, strategy, and people. Supported by family, mentors, and close professional allies, Dr. Rajeev Agarwal entered the pharmaceutical industry with curiosity and persistence, qualities that have guided him through both breakthroughs and challenges. His professional journey began in 1995 at Elan Pharma, where he mastered the art of relaunching territories and driving brand momentum, notably steering Rinifoll to become India’s No. 1 brand. Subsequent leadership roles at Modi Mundi, Life Medicare, and Ferring Pharma allowed him to sharpen his expertise in establishing market leadership and launching portfolios in IVF, gynecology, cardiology, and gastroenterology, while expanding institutional and IVF-center business. A recurring theme in his career has been building divisions from scratch, exemplified by launching and scaling the Gynova division at German Remedies and the Elena division at Alembic Pharma into multi-crore revenue generators. At Emcure Pharma, Dr. Agarwal faced one of his most significant challenges: transforming loss-making divisions into profitable businesses. During this tenure, he created ₹50 crore brands like Dydrofem in record time and pioneered innovative engagement initiatives such as EMIDOL, India’s first doctor-singing contest, alongside large-scale nurse training programs across 5,000 nursing homes. These efforts underscore his commitment to blending scientific rigor with human-centered outreach. Currently, as President of the Gufic Fertility Cluster and former head of multiple divisions at BSV Pharma, Dr. Agarwal leads large teams, drives P&L accountability, and partners with professional bodies to deliver measurable public health impact. His vision is to position Gufic as India’s leading fertility business by combining high purity, differentiated products with academic partnerships, scientific training academies, and impactful public health initiatives. Throughout his career, Dr. Agarwal has embodied resilience, a focus on mentored talent development, and unwavering dedication to scientific credibility. He views business growth as inseparable from advancing healthcare access and building ecosystems that foster lasting transformation in women’s health. He adds, “What began as a career opportunity nearly three decades ago has evolved into a mission to redefine fertility care in India through innovation, education, and sustainable growth.” Approach to Work-Life Integration Balancing a demanding pharmaceutical career with personal life has been a disciplined journey for Dr. Rajeev over 29 years. He has managed high-stakes roles, from turning around underperforming divisions to launching multi-crore brands and leading teams, while staying connected with family and personal interests. Dr. Rajeev’s approach hinges on clear priorities. Professionally, he drives decisions, whether on brand strategies or partnerships with organizations like FOGSI and ISAR, through structured planning and delegation. He believes no leader succeeds alone; empowering teams and setting clear Key Result Areas (KRAs) fosters growth and frees up personal time. Time management is central to his balance. The pharmaceutical industry demands long hours, travel, and constant engagement with doctors and institutions. Dr. Rajeev meticulously schedules family time, especially for weekends or milestones, recognizing that personal support fuels his professional resilience. He highlights, “Even in the busiest phases, I ensure that family commitments are honored because personal support has been the foundation of my professional resilience.” He views challenges as growth opportunities. Setbacks, such as leading loss-making divisions or introducing concepts like EMIDOL that faced initial skepticism, have built his resilience and patience. These are qualities that enrich his personal life. He consciously leaves work stress behind and uses challenges to reflect and adapt. Well-being is vital to Dr. Rajeev. He recharges through friends, reading, and continuous learning, while encouraging his teams to prioritize balance for better performance. For him, balance means allocating energy wisely, not dividing time equally. Through delegation, discipline, and perspective, Dr. Rajeev thrives professionally while remaining fulfilled personally. This equilibrium sustains his passion for impactful healthcare change, blending excellence in leadership with a meaningful personal life. Unconventional Path to Pharma Success Dr. Rajeev’s appetite for business stems from a passion for transformative impact in healthcare, beyond just revenue. He thrives on challenges, having relaunched Rinifoll to India’s top spot, built Gynova and Elena divisions from scratch, and turned Emcure’s loss-making units profitable. These successes showcase his drive for vision and execution. He finds joy in building by identifying unmet needs, crafting strategies, and leading teams to success. Initiatives like the FOGSI breastfeeding campaign or India’s first doctor-singing

Leadership is being reinvented on a grand scale. The old playscripts of hierarchy, linear strategy, and transactional management no longer apply in a world that changes by the hour. Disruption is ever-present, complexity the new norm, and uncertainty the only certainty. Here, genuine leaders differentiate themselves not by authority, but by vision. They foster trust rather than fear, ignite innovation rather than compliance, and create impact that resonates well beyond the balance sheet. The future belongs to those who are able to convert volatility into opportunity and lead with courage, clarity, and purpose. Into this gap comes Jivi Saran, CEO of Quantum Business Growth and Founder of The CEO Whisperer. She takes her inspiration from the principles of quantum science and combines these with conscious capitalism, systems thinking, and many decades’ worth of real-world advisory experience. In the process, she’s reframing leadership as an energy field- one that impacts the very essence of organizational life. Her philosophy is courageous but profoundly human: leadership is not so much about control as it is about resonance, not so much about directing as it is about creating spaces where possibility can grow. From this perspective, she has helped executives throughout Canada and internationally transition from process management to energy stewardship, leading not only their companies but the way they live and lead. The Evolution of a Quantum Leader Jivi Saran’s journey was not marked by one sudden revelation but by years of observing what didn’t work. Early in her career as a CEO and senior advisor, she repeatedly saw how linear strategies buckled under the weight of complexity. Companies obsessed with quarterly numbers often missed opportunities for deeper innovation. Leaders who focused solely on processes neglected the subtle but powerful human energy shaping outcomes behind the scenes. “Leadership models were simply too narrow,” she reflects. “They didn’t account for interdependence, emergent possibilities, or the fact that people are not machines. They are energetic beings influencing everything around them.” Her curiosity led her into systems thinking, spiritual intelligence, and conscious capitalism, where she began noticing striking parallels with quantum science. Her experience was in line with the quantum principle that observation changes reality: when leaders changed their energy, entire organisational fields changed as well. Over time, she developed the conviction that leadership is less about hierarchy and more about coherence. It revolves around aligning intention, presence, and values in ways that ripple throughout the system. This became the seed of her quantum leadership model, a philosophy she has since refined through rigorous research and hands-on executive practice. The CEO Whisperer: Decoding Leadership at Its Core The moniker The CEO Whisperer did not come from a branding consultant; it emerged organically. Executives consistently turned to Jivi Saran not just for strategies but for clarity, often inviting her into the most private and high stakes conversations. She became the person leaders trusted when they felt most vulnerable- when the future of their organizations, and sometimes their careers, hung in the balance. Her role was never about providing quick answers. Instead, she listened deeply, sensed unspoken dynamics, and helped leaders uncover insights they already carried but could not articulate. The “whisperer” title reflects this subtle art of drawing out hidden wisdom, realigning leaders with their authentic selves, and creating space where transformation naturally unfolds. Unlike conventional executive coaching, her approach is rooted in quantum principles. She doesn’t start with KPIs or performance metrics; she begins with alignment. Once a leader’s inner state resonates with clarity and purpose, measurable results follow. This creates changes that ripple through culture, strategy, and systems without forcing compliance or artificial motivation. Transformational Leadership in Action The practical impact of Saran’s work is best illustrated through stories of transformation. One mid-sized technology company’s CEO approached her amid internal conflict and stalled innovation. His style was highly transactional, crisis-driven, and rooted in control. Employees felt like replaceable parts, and morale was sinking. Rather than focusing on operational fixes, Saran guided him toward inner recalibration. She introduced practices of stillness before decision-making, shifted his framing from control to trust, and encouraged him to view leadership as shaping energy rather than issuing commands. The effects were profound. Within months, cross-functional collaboration revived, innovation pipelines reopened, and employee retention soared. Most strikingly, profitability rose, not from cost-cutting but from a surge in creativity and discretionary effort. “When leaders elevate their consciousness,” Saran explains, “organizations reorganize around that frequency. It’s exponential.” Another case involved a healthcare executive who was resistant to stakeholder engagement. He was convinced it would dilute efficiency. Through resonance mapping, Saran showed him how mistrust and disengagement were slowing projects more than any regulatory hurdle. By aligning his presence with genuine openness, he transformed resistance into collaboration, cutting implementation timelines by nearly half. Conscious Capitalism as a Competitive Edge Saran champions conscious capitalism, but she does so strategically. She knows many leaders equate it with philanthropy or performance compromise. Conscious capitalism, she argues, is not charity; it is a superior operating system. Her evidence is compelling. She draws on case studies of organizations outperforming peers because they embedded purpose and stakeholder well-being into their core strategies. In her advisory sessions, she uses scenario planning and stakeholder mapping to reveal hidden risks in profit-maximisation-only models. Often, leaders’ breakthrough moment comes when they realize that aligning personal values with organizational goals not only feels right but also produces durable advantages: stronger brand loyalty, more engaged talent, and greater resilience during disruptions. “Purpose is not a cost center,” she insists. “It’s your competitive edge.” Bridging Theory and Practice Where Saran excels is in translation- taking complex ideas from academia and making them actionable for executives. Quantum concepts like non-linearity and interconnectedness may seem abstract, but she grounds them in practical rituals: Stillness before decisions as a method for accessing clarity. Scenario planning as probability mapping rather than prediction. Resonance mapping to assess alignment across stakeholders. These practices integrate seamlessly into governance and strategy, so leaders don’t see them as “extra work” but as smarter ways of operating.

In a world where science is often expressed through equations and formulae, Anne and Don Lakmanaarachchi choose to tell their journey through awe and purpose. Together, they founded PhytoAR Biotechnologie GmbH, a company at the crossroads of nature and innovation, transforming the silent intelligence of plants into powerful instruments for the planet’s future. Anne, Chief Operating Officer and a scientist by heart and a business chemist by education, brings deep insights into the molecular language of life. Don, Managing Director and a seasoned global entrepreneur, contributes decades of experience in international leadership and agricultural innovation. Their paths could not have been more different, yet it was precisely this contrast that made their vision possible. From pioneering molecular plant research to building one of the most forward-looking biotechnology enterprises in Europe, they both are redefining how science and strategy intertwine. Guided by curiosity, courage, and compassion, they have transformed complex research into life-affirming innovation, leading a diverse team of experts who share a singular belief: that growth is more than a biological process, it is a concept, a mindset, and a shared responsibility. When Two Paths Converge Anne combined her fascination for life’s molecular beauty with business insight, earning a degree in Business Chemistry at Christian-Albrechts University in Kiel. At Bayer’s subsidiary Ehrfeld Mikrotechnik, she advanced to Head of Marketing, mastering the art of translating complex technologies into clear strategic visions—an ability that defines her leadership today. Thousands of miles away from where Anne’s story began in Northern Germany, Don grew up in Sri Lanka, attending Ananda College—the country’s premier institution where leadership and discipline became early cornerstones. His studies and career took him across continents, from Australia to global development projects funded by the World Bank, USAID, GTZ, and the European Union. He was among the early adopters of GIS-based decision systems to optimize agricultural practices, pioneering ideas that would later evolve into what we now call precision farming. His leadership in managing large, multimillion-dollar projects paved the way for his role as CEO. When Anne and Don met in Germany, their paths aligned as if by design. In their very first conversations, they recognized the same vision: that growth, whether of plants, people, or ideas, could be redefined. Out of loss and ambition, out of science and leadership, PhytoAR Biotechnologie was born. Decoding Nature’s Ancient Wisdom “The story of PhytoAR began not with a product, but with a question: what if the hidden intelligence of plants could be understood, captured, and shared?” Don reflects. Working alongside brilliant minds, including Dr. Dr. Dieter Mahr, a lifelong mentor whose doctorate roots include space science Don uncovered insights pointing to an astonishing truth: resilience and growth in plants are not accidents, but carefully orchestrated molecular strategies. What most people don’t realize is that chloroplasts, the tiny green engines in every leaf were once independent bacteria, ancient beings that entered into a pact with plants millions of years ago. Today, they still act like command centers of life, regulating not only energy but also growth, resilience, and survival. They function almost like miniature brains. The most fascinating discovery lies in the chloroplasts of seedlings. A seedling has no choice: it cannot move to a kinder place or wait for better weather. Where it falls, it must fight to live. In that struggle, nature has encoded a survival program more urgent and refined than at any other stage of life. Out of thousands of seeds, only the strongest endure and the chloroplasts hold the molecular script of this fight. At PhytoAR, the team found a way to capture this script. By extracting messenger RNA from seedling chloroplasts, they can transfer their survival code to other plants by granting them resilience, adaptability, and the power to grow against the odds. “It is less an invention than a revelation: the ancient wisdom of life itself, unlocked for the future of our planet,” Anne explains. This breakthrough not only opens new frontiers in agriculture on Earth but also holds transformative potential for future Moon and Mars missions. Interestingly, this brings Dieter’s career full circle: one of his doctoral theses was dedicated to space research, linking his early work on plant biology in microgravity directly to the cutting-edge innovations PhytoAR pioneers today. The Art of Balance Leading a pioneering biotechnology company while maintaining personal equilibrium presents constant challenges. Yet for Anne and Don, this balance gives their work meaning. PhytoAR is not simply a profession, it’s a mission. And missions require energy, focus, and the wisdom to pause. For her, balance has always been rooted in her connection to nature. She finds strength in small, quiet moments: the smell of freshly cut grass, the sound of leaves in the wind, the grounding presence of open landscapes. Although Don once bought beautiful garden chairs, Anne often prefers to lie directly on the grass, fully immersed in the earth’s rhythm. “Don sometimes jokes that he must be careful not to step on her as he walks by. These simple moments remind us both of the essence of our work: to give life, in its most natural form, a voice,” she laughs. For Don, perspective is key. Having lived and worked across continents, he knows that stress is inevitable, but resilience is a choice. Early in his career, when managing large projects, he learned to stay calm under pressure and focus on the bigger picture. Today, he brings that same clarity to PhytoAR, reminding the team that every challenge carries within it the seed of progress. When the day feels particularly overwhelming, he has a simple personal ritual: a glass of whiskey to pause, reflect, and reset. Together, they strive to create boundaries where possible—safeguarding time for themselves, for laughter, for the simple rituals that make life human. Yet they also accept that their professional and personal worlds blend seamlessly. Some of their most creative ideas have been born not in a boardroom, but during evening walks, lighthearted conversations in the garden, or quiet moments of reflection. “Our balance, in the end,